Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
August 29 2022 - 4:30PM
Conformis, Inc. (NASDAQ: CFMS), a leading medical device
company that features personalized knee and hip replacement
products, announced today that Mark Augusti, Chief Executive
Officer, and Bob Howe, Chief Financial Officer, will participate in
the H.C. Wainwright & Co. 24th Annual Global Investment
Conference.
The hybrid conference will take place September
12-14, 2022. The conference will be held at the Lotte New York
Palace Hotel and will include virtual and in-person participation.
Some of the best and most promising growth companies in life
sciences, cryptocurrency/fintech, TMT, and cleantech are expected
to participate.
- Conformis management will participate virtually via an
on-demand presentation which will be available starting on
September 12, 2022 at 7:00 a.m. ET.
- Link to CFMS Presentation Video
Conformis management will also be available for
virtual one-on-one meetings throughout the conference. For more
information about the conference or to schedule a one-on-one
meeting with management, please contact your H.C. Wainwright
representative or Conformis Investor Relations at ir@conformis.com
and (781) 374-5598.
The replay of the presentation will be available
under "Events and Presentations" in the Investors section of the
Conformis website at ir.conformis.com. A replay of the webcast will
be archived on Conformis' website for 90 days following the
presentation.
About Conformis, Inc.
Founded in 2004, Conformis is a medical
technology company focused on advancing orthopedic patient care and
creating a world without joint pain. Its product portfolio is
designed to maximize surgeon and patient choice by offering fully
personalized solutions through its Image-to-Implant® Platinum
Services℠ Program as well as data-informed, standardized solutions
that combine many benefits of personalization with the convenience
and flexibility of an off-the-shelf system. Conformis’ sterile,
just-in-time, Surgery-in-a-Box™ delivery system is available with
all of its implants and personalized, single-use instruments.
Conformis owns or exclusively in-licenses issued patents and
pending patent applications that cover personalized implants and
patient-specific instrumentation for all major joints. For more
information, visit www.conformis.com. To receive future press
releases via e-mail alerts, sign up at ir.conformis.com.
Investor
Contact:ir@conformis.com(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Apr 2023 to Apr 2024